Commit Biologics appoints accomplished R&D executive, Dr Janine Schuurman, to its Board of Directors

Commit Biologics United Kingdom United States of America Denmark

Former senior vice president of antibody research at Genmab who has co-invented numerous FDA-approved therapeutic antibodies and as well as its DuoBody® bi-specific antibody platformBrings decades of experience in developing strong pipelines of antibody-based drugs from platforms, growing scientific teams and managing partnerships with Pharma companiesAppointment comes as Commit looks to progress towards drug candidate (DC) nomination in cancer and autoimmune disease in 2025 View original content:https://www.prnewswire.co.uk/news-releases/commit-biologics-appoints-accomplished-rd-executive-dr-janine-schuurman-to-its-board-of-directors-302344961.html